RaySearch Laboratories AB (publ) (RAY-B.ST)
SEK 205.0
(1.49%)
SEK 205.0
(1.49%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 9.32 Million SEK | -33.86% |
| 2022 | 14.09 Million SEK | -53.02% |
| 2021 | 29.99 Million SEK | 229.21% |
| 2020 | 9.11 Million SEK | 97.06% |
| 2019 | 4.62 Million SEK | -51.93% |
| 2018 | 9.61 Million SEK | 29042.42% |
| 2017 | 33 Thousand SEK | 0.0% |
| 2016 | - SEK | -100.0% |
| 2015 | 1.00 SEK | 0.0% |
| 2014 | 1.00 SEK | 0.0% |
| 2013 | 1.00 SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| 2011 | - SEK | 0.0% |
| 2010 | - SEK | 0.0% |
| 2009 | - SEK | 0.0% |
| 2008 | - SEK | 0.0% |
| 2007 | - SEK | 0.0% |
| 2006 | - SEK | 0.0% |
| 2005 | - SEK | 0.0% |
| 2004 | - SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 21.1 Million SEK | 45.34% |
| 2024 Q1 | 14.51 Million SEK | 55.77% |
| 2023 Q2 | 26.64 Million SEK | 16.2% |
| 2023 Q4 | 9.32 Million SEK | -52.98% |
| 2023 Q3 | 19.82 Million SEK | -25.59% |
| 2023 FY | 9.32 Million SEK | -33.86% |
| 2023 Q1 | 22.92 Million SEK | 62.7% |
| 2022 FY | 14.09 Million SEK | -53.02% |
| 2022 Q3 | 29.44 Million SEK | -32.98% |
| 2022 Q4 | 14.09 Million SEK | -52.14% |
| 2022 Q1 | 38.45 Million SEK | 28.21% |
| 2022 Q2 | 43.93 Million SEK | 14.26% |
| 2021 Q4 | 29.99 Million SEK | 40.84% |
| 2021 Q2 | 20.31 Million SEK | -8.44% |
| 2021 Q3 | 21.29 Million SEK | 4.81% |
| 2021 Q1 | 22.18 Million SEK | 143.57% |
| 2021 FY | 29.99 Million SEK | 229.21% |
| 2020 FY | 9.11 Million SEK | 97.06% |
| 2020 Q2 | 8.2 Million SEK | 4.79% |
| 2020 Q3 | 13.76 Million SEK | 67.74% |
| 2020 Q4 | 9.11 Million SEK | -33.79% |
| 2020 Q1 | 7.82 Million SEK | 69.33% |
| 2019 FY | 4.62 Million SEK | -51.93% |
| 2019 Q1 | 2.93 Million SEK | -69.52% |
| 2019 Q2 | 3.85 Million SEK | 31.39% |
| 2019 Q3 | 14.31 Million SEK | 271.72% |
| 2019 Q4 | 4.62 Million SEK | -67.71% |
| 2018 Q2 | 525 Thousand SEK | -43.0% |
| 2018 Q4 | 9.61 Million SEK | 4155.31% |
| 2018 FY | 9.61 Million SEK | 29042.42% |
| 2018 Q1 | 921 Thousand SEK | 2690.91% |
| 2018 Q3 | 226 Thousand SEK | -56.95% |
| 2017 Q3 | 722 Thousand SEK | 72199900.0% |
| 2017 Q2 | 1.00 SEK | 0.0% |
| 2017 Q4 | 33 Thousand SEK | -95.43% |
| 2017 Q1 | 1.00 SEK | 100.0% |
| 2017 FY | 33 Thousand SEK | 0.0% |
| 2016 FY | - SEK | -100.0% |
| 2016 Q2 | -266.16 Million SEK | -26616400693.23% |
| 2016 Q1 | -1.00 SEK | -200.0% |
| 2016 Q4 | -282.53 Million SEK | 2.44% |
| 2016 Q3 | -289.59 Million SEK | -8.8% |
| 2015 FY | 1.00 SEK | 0.0% |
| 2015 Q4 | 1.00 SEK | 100.0% |
| 2015 Q2 | -156.8 Million SEK | 9.82% |
| 2015 Q1 | -173.88 Million SEK | -17388200100.0% |
| 2015 Q3 | -188.31 Million SEK | -20.1% |
| 2014 FY | 1.00 SEK | 0.0% |
| 2014 Q3 | - SEK | 100.0% |
| 2014 Q1 | -88.98 Million SEK | -8898700100.0% |
| 2014 Q2 | -94.57 Million SEK | -6.28% |
| 2014 Q4 | 1.00 SEK | 3355443300.0% |
| 2013 Q2 | -64.53 Million SEK | -1.95% |
| 2013 FY | 1.00 SEK | 0.0% |
| 2013 Q4 | 1.00 SEK | 100.0% |
| 2013 Q3 | -62.1 Million SEK | 3.76% |
| 2013 Q1 | -63.3 Million SEK | -19.44% |
| 2012 FY | - SEK | 0.0% |
| 2012 Q1 | - SEK | 0.0% |
| 2012 Q3 | -47.63 Million SEK | 0.0% |
| 2012 Q4 | -53 Million SEK | -11.28% |
| 2012 Q2 | - SEK | 0.0% |
| 2011 Q1 | - SEK | 0.0% |
| 2011 FY | - SEK | 0.0% |
| 2011 Q2 | - SEK | 0.0% |
| 2011 Q3 | - SEK | 0.0% |
| 2011 Q4 | - SEK | 0.0% |
| 2010 Q1 | - SEK | 0.0% |
| 2010 FY | - SEK | 0.0% |
| 2010 Q4 | - SEK | 0.0% |
| 2010 Q3 | - SEK | 0.0% |
| 2010 Q2 | - SEK | 0.0% |
| 2009 Q4 | - SEK | 0.0% |
| 2009 FY | - SEK | 0.0% |
| 2008 FY | - SEK | 0.0% |
| 2007 FY | - SEK | 0.0% |
| 2006 FY | - SEK | 0.0% |
| 2005 FY | - SEK | 0.0% |
| 2004 FY | - SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aino Health AB (publ) | -649 Thousand SEK | 1536.055% |
| Bonzun AB (publ) | - SEK | -Infinity% |
| Kontigo Care AB (publ) | 1.00 SEK | -931999900.0% |
| Medhelp Care Aktiebolag (publ) | 1.00 SEK | -931999900.0% |
| Surgical Science Sweden AB (publ) | 154.45 Million SEK | 93.966% |